Delvosteron, 100 mg/ml suspensie voor injectie voor honden en katten
Delvosteron, 100 mg/ml suspensie voor injectie voor honden en katten
Not authorised
- Proligestone
Product identification
Medicine name:
Delvosteron, 100 mg/ml suspensie voor injectie voor honden en katten
Active substance:
- Proligestone
Target species:
-
Dog
-
Cat
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Proligestone100.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Dog
-
Cat
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QG03DA90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Netherlands
Package description:
- Available only in Dutch
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Intervet Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Intervet International B.V.
Responsible authority:
- Medicines Evaluation Board
Authorisation number:
- REG NL 4119
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Dutch (PDF)
Published on: 22/02/2022
How useful was this page?:
